Redirecting to https://newsroom.astellas.us/2019-12-16-XTANDI-R-enzalutamide-Approved-by-U-S-FDA-for-the-Treatment-of-Metastatic-Castration-Sensitive-Prostate-Cancer...

Click here if your browser doesn't automatically take you to this page.